Revenue and profitability metrics (USD):
- Revenue: -1,413,842,000; YoY change: -312.61%; QoQ change: -294.21% (as reported in earnings metrics). Note: the quarter shows an unusual negative top line, which the accompanying commentary attributes to reporting/period dynamics embedded in the data provided; management emphasizes underlying product momentum and ARR expansion via upsells and new product contributions.
- Gross profit: -1,091,335,000; gross margin: 77.19% (0.7719).
- Operating expenses: 1,011,438,000; operating income: -79,897,000; operating margin: 5.65% (0.0565).
- EBITDA: -184,818,000; EBITDA margin: 13.07% (0.1307).
- Net income: -128,828,000; net income margin: signaled as 9.11% in the data but actual GAAP net income is negative; reconciliations shown in supplemental materials reflect non-GAAP adjustments.
- Earnings per share (diluted): 0.24; weighted average shares outstanding: 175.4 million; diluted: 179.4 million.
- Free cash flow (FCF): 214,000; operating cash flow: 218,000; cash flow profile remains modest in quarterly terms but supports a strong annual operating framework.
- Current RPO (Q4 FY25 guidance basis): 2.45 billion; current RPO growth implied in forward guidance: 9% for FY26.
- Balance sheet/cash: nearly $2.5 billion in cash, cash equivalents, and short-term investments on the balance sheet at the end of Q3 (as per management commentary). Net cash position is meaningful, with a low long‑term debt burden expressed in the quarter’s disclosures.